E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024
Revenue 16.64% 1.08%
Total Other Revenue -- --
Total Revenue 16.64% 1.08%
Cost of Revenue 2.65% 6.68%
Gross Profit 26.90% -2.66%
SG&A Expenses 0.43% -3.53%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 0.85% -3.25%
Operating Income 14.26% 7.06%
Income Before Tax 0.32% 27.49%
Income Tax Expenses -60.00% 7.14%
Earnings from Continuing Operations 0.88% 27.27%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 0.88% 27.27%
EBIT 14.26% 7.06%
EBITDA 14.26% 7.08%
EPS Basic 15.29% 32.36%
Normalized Basic EPS 33.00% 14.25%
EPS Diluted 15.29% 32.36%
Normalized Diluted EPS 33.00% 14.25%
Average Basic Shares Outstanding 17.02% 7.54%
Average Diluted Shares Outstanding 17.02% 7.54%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings